Affiliation:
1. Departments of Clinical Microbiology
2. Immunology, University of Copenhagen, Copenhagen, Denmark
3. Pathology
4. Pediatrics, Clinic II, University State Hospital, Rigshospitalet
Abstract
ABSTRACT
Parvovirus B19 (hereafter referred to as B19) exhibits a marked tropism to human bone marrow (BM), and infection may lead to erythema infectiosum, arthropathy, hydrops fetalis, and various hematologic disorders. Recently, a distinct parvovirus isolate termed V9 with an unknown clinical spectrum was discovered. In contrast to the many studies of B19 serology and viremia, valid information on the frequency of B19 or V9 DNA in the BM of healthy individuals is limited. To develop a reference value, paired BM and serum samples from healthy subjects were tested for the presence of B19 and V9 DNA and specific antibodies. Immunoglobulin M (IgM) was not found in any of the serum samples. The prevalence of IgG showed a gradual and steady increase from 37% in children aged 1 to 5 years to 87% in people aged >50 years. When 190 well-characterized subjects were examined, B19 DNA was detected in the BM of 4 individuals (2.1%; 95% confidence interval, 0.58 to 5.3%) while none of the paired serum samples showed evidence of circulating viral DNA. V9 DNA was not found in any of the BM or serum samples. The finding of B19 DNA probably indicated a primary infection in one 7-year-old individual and reinfection or reactivation of persistent infection in the remaining three persons, aged 47 to 58 years. Serving as a benchmark for future studies, these findings are useful when interpreting epidemiologic data, performing BM transplantation, or considering clinical implications of parvovirus infection.
Publisher
American Society for Microbiology
Reference24 articles.
1. Anderson, L. J. 1987. Role of parvovirus B19 in human disease. Pediatr. Infect. Dis. J.6:711-718.
2. Broliden, K., T. Tolfvenstam, S. Ohlsson, and J. I. Henter. 1998. Persistent B19 parvovirus infection in pediatric malignancies. Med. Pediatr. Oncol.31:66-72.
3. Brown, K. E. 2000. Haematological consequences of parvovirus B19 infection. Baillieres Best Pract. Res. Clin. Haematol.13:245-259.
4. Brown, K. E., N. S. Young, B. M. Alving, and L. H. Barbosa. 2001. Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion41:130-135.
5. Cassinotti, P., G. Burtonboy, M. Fopp, and G. Siegl. 1997. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J. Med. Virol.53:229-232.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献